Literature DB >> 33368196

von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients.

Maxime Delrue1,2, Virginie Siguret1,3, Marie Neuwirth1,3, Bérangère Joly1,2, Nicolas Beranger1,2, Damien Sène4, Benjamin G Chousterman5,6, Sebastian Voicu7,8, Philippe Bonnin9,10,11, Bruno Mégarbane7,8, Alain Stépanian1,2.   

Abstract

Entities:  

Keywords:  ADAMTS13; COVID-19; venous thrombosis; von Willebrand factor

Mesh：

Substances：

Year:  2020        PMID： 33368196     DOI： 10.1111/bjh.17216

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  13 in total

Review 1.  COVID-19 and thrombosis: searching for evidence.

Authors:  Bright Thilagar; Mohamad Beidoun; Ruben Rhoades; Scott Kaatz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients.

Authors:  Sebastian Voicu; Chahinez Ketfi; Alain Stépanian; Benjamin G Chousterman; Nassim Mohamedi; Virginie Siguret; Alexandre Mebazaa; Bruno Mégarbane; Philippe Bonnin
Journal:  Front Physiol       Date:  2021-01-08       Impact factor: 4.566

Review 3.  Hematological changes associated with COVID-19 infection.

Authors:  Enass Abdul Kareem Dagher Al-Saadi; Marwa Ali Abdulnabi
Journal:  J Clin Lab Anal       Date:  2021-11-16       Impact factor: 3.124

Review 4.  High levels of Von Willebrand factor markers in COVID-19: a systematic review and meta-analysis.

Authors:  Mehrdad Rostami; Hassan Mansouritorghabeh; Mohammad Parsa-Kondelaji
Journal:  Clin Exp Med       Date:  2021-11-06       Impact factor: 5.057

Review 5.  Non-Coding RNAs in COVID-19: Emerging Insights and Current Questions.

Authors:  Tobias Plowman; Dimitris Lagos
Journal:  Noncoding RNA       Date:  2021-08-31

6.  Low ADAMTS-13 predicts adverse outcomes in hospitalized patients with suspected heparin-induced thrombocytopenia.

Authors:  Meng Chan; Xinyang Zhao; X Long Zheng
Journal:  Res Pract Thromb Haemost       Date:  2021-09-16

Review 7.  Pathogenesis of Two Faces of DVT: New Identity of Venous Thromboembolism as Combined Micro-Macrothrombosis via Unifying Mechanism Based on "Two-Path Unifying Theory" of Hemostasis and "Two-Activation Theory of the Endothelium".

Authors:  Jae C Chang
Journal:  Life (Basel)       Date:  2022-01-31

8.  SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes.

Authors:  Yijia Li; Alexis M Schneider; Arnav Mehta; Moshe Sade-Feldman; Kyle R Kays; Matteo Gentili; Nicole C Charland; Anna Lk Gonye; Irena Gushterova; Hargun K Khanna; Thomas J LaSalle; Kendall M Lavin-Parsons; Brendan M Lilley; Carl L Lodenstein; Kasidet Manakongtreecheep; Justin D Margolin; Brenna N McKaig; Blair A Parry; Maricarmen Rojas-Lopez; Brian C Russo; Nihaarika Sharma; Jessica Tantivit; Molly F Thomas; James Regan; James P Flynn; Alexandra-Chloé Villani; Nir Hacohen; Marcia B Goldberg; Michael R Filbin; Jonathan Z Li
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

9.  Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.

Authors:  György Sinkovits; Marienn Réti; Veronika Müller; Zsolt Iványi; János Gál; László Gopcsa; Péter Reményi; Beáta Szathmáry; Botond Lakatos; János Szlávik; Ilona Bobek; Zita Z Prohászka; Zsolt Förhécz; Blanka Mező; Dorottya Csuka; Lisa Hurler; Erika Kajdácsi; László Cervenak; Petra Kiszel; Tamás Masszi; István Vályi-Nagy; Zoltán Prohászka
Journal:  Thromb Haemost       Date:  2022-01-21       Impact factor: 5.249

10.  Verification of the Role of ADAMTS13 in the Cardiovascular Disease Using Two-Sample Mendelian Randomization.

Authors:  Zixiang Ye; Jingang Zheng
Journal:  Front Genet       Date:  2021-07-01       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.